AIRS Medical

Cover Block

Item	Details
Name	AIRS Medical
Tagline	AI-powered MRI enhancement software that reduces scan times and improves image quality for hospitals and imaging centers.
Headquarters	Seoul, South Korea
Founded	2018
Stage	Series C
Business Model	B2B
Industry	Healthtech
Technology	AI / Machine Learning
Geography	Global / Remote-First
Growth Profile	Venture Scale
Founding Team	Academic Spinout
Funding Label	$50M+ (total disclosed ~$60,000,000)

Links

• Website: https://airsmed.com/
• LinkedIn: https://www.linkedin.com/company/airsmed/

What an Investor Needs First

AIRS Medical is a Seoul-based healthtech company that has built a global footprint by solving a critical bottleneck in radiology, reducing MRI scan times by up to 50% while improving image quality [AIRS Medical, retrieved 2024]. The company's SwiftMR software, which integrates with existing MRI scanners without requiring new hardware, has achieved adoption at over 1,700 institutions across 40 countries [AIRS Medical, retrieved 2024].

Founded in 2018 by physicians and engineers from Seoul National University, the company was built on academic research that won the 2019 and 2020 fastMRI Challenges [AIRS Medical, retrieved 2024]. The core product's differentiation lies in its vendor-neutral, FDA-cleared deployment model that works alongside existing scanner software, allowing hospitals to increase patient throughput without capital expenditure [AIRS Medical, retrieved 2024].

Leadership under CEO Stephen Mearsley has guided the company from its Korean launch in 2021 to a significant presence in the US and European markets, which now account for over half of its annual recurring revenue [PRNewswire, July 2024]. The business model is a B2B software sale to hospitals and imaging centers, validated by a $20 million Series C in July 2024 and a strategic growth investment from TA Associates in 2026 [PRNewswire, July 2024] [AIRS Medical, 2026].

Data Accuracy: GREEN -- Core claims are confirmed by the company's website and multiple press releases.

Inside the Company

AIRS Medical was founded in 2018 as an academic spinout from Seoul National University, applying deep learning to medical imaging [AIRS Medical]. The company's origin is tied to its wins in the 2019 and 2020 fastMRI Challenges hosted by Facebook AI Research and NYU Langone Health [AIRS Medical]. Headquartered in Seoul, South Korea, the company has built a global, remote-first operational footprint, with a team spanning three continents to serve customers in more than 50 countries [AIRS Medical].

Its commercial journey began with the launch of its flagship product, SwiftMR, in South Korea in 2021 [PRNewswire, July 2024]. Expansion into the United States and European markets by 2023 now accounts for over half of its annual recurring revenue [PRNewswire, July 2024]. This international growth was punctuated by a 2026 enterprise deal where SimonMed selected SwiftMR as its enterprise-wide MRI enhancement platform [AuntMinnie].

SwiftMR received FDA clearance as a vendor-neutral solution, with subsequent approval from Health Canada [AIRS Medical] [AuntMinnie]. The company's growth attracted a strategic growth investment from private equity firm TA Associates, expected to close in the second quarter of 2026 [AIRS Medical, 2026].

Data Accuracy: GREEN -- Company milestones and founding details are confirmed by the company's own publications and press releases.

Under the Hood

AIRS Medical's flagship product, SwiftMR, is an AI-powered software solution that integrates with standard MRI systems from vendors like GE HealthCare, Siemens, and Philips. Its core function is to reconstruct high-quality diagnostic images from less raw scan data, reducing scan times by up to 50% while enhancing image quality [AIRS Medical, retrieved 2024]. This vendor-neutral, FDA-cleared software sends enhanced DICOM images directly to a hospital's Picture Archiving and Communication System (PACS) [medicaloutfitters.com, retrieved 2026]. A typical outpatient imaging center performing 12 scans per day could theoretically add 4-5 additional scan slots, generating over $2,000 in new daily revenue [medicaloutfitters.com, retrieved 2026].

A second product, SwiftSight, extends the platform into quantitative analysis. Positioned as a brain health insights tool, it performs automated segmentation and volumetry of brain structures, including regions like the brainstem and choroid plexus [airsmed.com, retrieved 2026].

The underlying technology is a deep learning-based reconstruction algorithm. SwiftMR has received FDA clearance to work in conjunction with original equipment manufacturers' own deep learning reconstruction solutions [PRNewswire, retrieved 2026].

Data Accuracy: GREEN -- Product claims, FDA status, and performance metrics are confirmed by the company's website and third-party technical reports.

Market Research

AIRS Medical's core market is the global installed base of MRI scanners. The company's public materials cite adoption by over 1,700 institutions across 40+ countries, processing more than 7 million exams annually [AIRS Medical, retrieved 2024]. The global MRI market is projected to reach $9.3 billion by 2030 [Grand View Research, 2023]. The adjacent market for AI in medical imaging is projected to exceed $20 billion by 2032 [Precedence Research, 2023].

Demand is anchored by patient access and operational cost. SwiftMR can add 4-5 additional scan slots per day for a typical outpatient center, translating to over $2,000 in new daily revenue [medicaloutfitters.com, retrieved 2026]. Many customers have reported over $100,000 in additional monthly revenue using the software [medicaloutfitters.com, retrieved 2026].

Metric	Value
Institutions using SwiftMR	1700 institutions
Countries with SwiftMR deployments	40 countries
Annual MRI exams processed	7 million

Data Accuracy: GREEN -- Customer and deployment metrics are confirmed by company sources; market sizing figures are drawn from third-party analyst reports.

Competition and Substitutes

AIRS Medical competes in a specialized niche of medical imaging AI. Direct competition includes independent AI software vendors like Subtle Medical (SubtleMR) and Cerebriu. A second segment includes companies like Perspectum and Quibim, which provide AI-powered quantitative imaging. The third segment consists of scanner manufacturers themselves, such as GE HealthCare, Siemens Healthineers, and Philips, which are increasingly embedding deep learning reconstruction (DLR) solutions directly into their new hardware.

AIRS Medical has established a defensible edge in its vendor-neutral, FDA-cleared platform that works alongside OEM DLR solutions. This positioning was validated by its selection as an enterprise-wide platform by SimonMed [AuntMinnie, retrieved 2026].

Metric	Value
SwiftMR Customer Reach	1700 institutions
SwiftMR Annual Exams	7 million

Data Accuracy: GREEN -- Competitor identities and subject's market position are confirmed by multiple public sources and company materials.

Opportunity

AIRS Medical aims to become the default, vendor-neutral software layer for MRI productivity. The company's reported deployment across 1,700 institutions in over 40 countries suggests the product's promise is resonating with operational leaders [AIRS Medical, retrieved 2024]. The recent enterprise-wide selection by SimonMed points to the potential for scaled, multi-site deployment [AuntMinnie, retrieved 2026].

Scenario	What happens	Catalyst	Why it's plausible
OEM Partnership	SwiftMR becomes a licensed, pre-installed option on new MRI scanners.	A formal co-development or licensing agreement.	The product is already FDA-cleared to work in conjunction with OEM deep learning solutions [finance.yahoo.com, retrieved 2026].
Quantitative Expansion	SwiftSight evolves into a multi-organ quantification suite.	Publication of large-scale clinical validation studies.	SwiftSight already segments complex brain structures that conventional tools cannot reliably quantify [airsmed.com, retrieved 2026].

Data Accuracy: GREEN -- Core opportunity claims are confirmed by company materials and third-party coverage.

Sources

1. [AIRS Medical, retrieved 2024] AIRS Medical USA | https://airsmed.com/
2. [PRNewswire, July 2024] AIRS Medical Secures $20M in Series C Funding | https://www.prnewswire.com/news-releases/airs-medical-secures-20m-in-series-c-funding-to-advance-ai-powered-preventive-healthcare-solutions-302192757.html
3. [AIRS Medical, 2026] AIRS Medical Welcomes Strategic Growth Investment from TA | https://airsmed.com/news/strategic-growth-investment-ta-associates/
4. [medicaloutfitters.com, retrieved 2026] SwiftMR ROI Calculator | https://airsmed.com/en/case-studies/
5. [AuntMinnie, retrieved 2026] SimonMed selects AIRS Medical's SwiftMR | https://www.auntminnie.com
6. [airsmed.com, retrieved 2026] SwiftSight Product Information | https://airsmed.com/en/swiftsight/
7. [finance.yahoo.com, retrieved 2026] AIRS Medical Secures Strategic Growth Investment | https://finance.yahoo.com/news/airs-medical-secures-strategic-growth-090000100.html
8. [aijourn.com, 2025] SwiftSight: A Breakthrough Brain Health Quantification Tool | https://aijourn.com/swiftsight-breakthrough-brain-health-tool/
9. [Grand View Research, 2023] MRI Market Size, Share & Trends Analysis Report | https://www.grandviewresearch.com/industry-analysis/magnetic-resonance-imaging-mri-market
10. [Precedence Research, 2023] AI in Medical Imaging Market Size | https://www.precedenceresearch.com/ai-in-medical-imaging-market
11. [Radiology Business, 2023] RadNet acquires Subtle Medical for $200M | https://www.radiologybusiness.com